Viewing nowDajibio New Jeong 50 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

MFDS item code 202004044 · Approved 2020.05.29 · Insurance code 649807910
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes as an adjunct to diet and exercise. It can be administered alone when initiating treatment. If monotherapy is insufficient, it may be used in combination with metformin. Additionally, it is added to treatment regimens when blood sugar control is difficult with single therapies or in combinations including sulfonylureas, metformin, thiazolidinediones, or insulin. These combination therapies may consist of various drug combinations. In summary, this drug effectively improves blood sugar control in patients with type 2 diabetes.
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. It may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Since dose adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. The dose for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2) is 50 mg once daily. 4. The dose for patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2) is 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.
This medication may rarely cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after administration, it should be discontinued immediately and medical advice should be sought. While taking this medication, there can be serious side effects such as acute pancreatitis, which involves inflammation of the pancreas, so if abdominal pain, vomiting, or severe abdominal discomfort occurs, notify medical staff immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in cases of allergies to the drug or its ingredients. Patients with impaired renal function may require dosage adjustments; thus, those with kidney disease or issues regarding kidney function should consult with a physician to determine the appropriate dose. This medication may cause symptoms of hypoglycemia, particularly if taken with other blood-sugar-lowering agents such as insulin or sulfonylureas, necessitating careful monitoring of blood sugar levels. Severe joint pain or skin disorders such as blistering dermatosis similar to pemphigus may occur; thus, medical staff should be notified immediately if these symptoms arise. Pregnant or breastfeeding women are advised not to take this medication, and safety in pediatric patients under 18 years of age has not been established, so it is recommended not to use it. This medication may interact with other drugs; hence, it is essential to inform medical staff about other medications currently being taken and to consult for advice. In case of an overdose, standard treatment such as removal of the medication from the gastrointestinal tract is necessary, and some may be removed through dialysis, so appropriate actions should be taken following medical staff directions. The elderly may experience decreased kidney function, thus requiring regular assessment of renal function before and during treatment with this medication, and dosage adjustments may be necessary.
Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative dermatitis, acute pancreatitis, hypoglycemia, upper respiratory tract infections, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe arthralgia accompanied by disabilities, blistering dermatitis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, severe hypoglycemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it is best kept at room temperature between 1 to 30 degrees Celsius. This will maintain the medication's effectiveness and ensure safe usage.
A pale yellow-pink, round, biconvex film-coated tablet
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.